FDA Approved: PIQRAY — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for PIQRAY (alpelisib) by Novartis, updating the label to include a new indication for HR-positive, HER2-negative advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Piqray (alpelisib)

Snippet

SUPPL AP for PIQRAY (ALPELISIB)